Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
Compared with adults, children produce a very different antibody response after infection with the new coronavirus, SARS-CoV-2, suggesting they clear the virus easily.
Magdalena Sobieszczyk, MD, chief of the division of infectious diseases at Columbia, explains how COVID-19 vaccine candidates work and their role in fighting the pandemic.
Community health workers at NYP/CUIMC were needed more than ever during the pandemic, helping patients access the resources they needed to stay healthy and safe.
The CUIMC Newsroom spoke with epidemiologist Dr. Sandra Albrecht about how to vote and celebrate the holidays this year while practicing good public health and staying safe from COVID.
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
Columbia/NYSPI researchers are examining how millions of college students are addressing COVID-19 challenges, including academic/life plans, decision-making, substance use, and mental well-being.
For mental health professionals, teletherapy can feel like it’s “one step removed,” although studies suggest it produces outcomes statistically equivalent to face-to-face treatment.
New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.